MedPath

Treatment of Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and Anti-bacterial Agents

Recruiting
Conditions
Pressure Ulcer
Disability or Chronic Disease Leading to Disablement
Osteomyelitis
Registration Number
NCT05713149
Lead Sponsor
Institut de Sante Parasport Connecte Synergies
Brief Summary

People with neuromotor disability (i.e. following an inborn or acquired spinal cord, cerebral or peripheral neurological lesion) are at high risk of osteomyelitis-associated pressure ulcers.

The management of osteomyelitis-associated pressure ulcers is controversial. In our center, patients benefit from a one stage surgical management with bone shaving and flap covering osteitis of pressure ulcer to perform wound closing. Surgery is followed by an antibiotic treatment, secondarily adapted to intraoperative samples.

The aim of this study is to describe the cohort and to identify factors associated with failure (or success) in this frail population.

Detailed Description

This is a prospective, monocentric, cohort study of neurological disabled inpatients subjects treated in the perioperative disability unit (UPOH) of our university hospital for osteomyelitis-associated pressure ulcer by surgical flaps and anti bacterial agents.

All eligible inpatient subjects with neuromotor disability and admitted for the treatment of osteomyelitis-associated pressure ulcers by surgical flaps will be consecutively included.

Patients are followed up in consultation at 30 or 45 days after surgery, and in consultation or teleconsultation at 12 months after surgery.

Data will be collected from the patients' medical records, in particular data related to their clinical, radiological, biological, and physiological examinations. Data related to sitting, nutrition, spasticity, bladder and bowel disorders, bacteriological sampling and antibiotic treatments will be collected.

This is a routine care study; no procedures are added for research purposes. It is an ancillary study to the NO-AGING study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Patients >= 18 years old ;
  • Treated in the Perioperative Disability Unit (UPOH) of the Physical Medicine and Rehabilitation Department of our university hospital;
  • Admitted for the treatment of an osteomyelitis-associated pressure ulcer by surgical flap;
  • Having a neuromotor disability;
  • No opposition to be enrolled in the study from the patient, or from a legally authorized close relative if the patient's state of health does not allow it;
  • Affiliation to a social security scheme.
Exclusion Criteria
  • Under court protection.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Success at 12 months after surgery12 months after surgery

Success is defined as the absence of surgical revision, the absence of additional antibiotic therapy, and the absence of local care at the surgical site.

Secondary Outcome Measures
NameTimeMethod
Success at 30-45 days after surgery30-45 days after surgery (depening on the surgical technique)

Success is defined as the absence of surgical revision, the absence of additional antibiotic therapy, and the absence of inflammatory signs or pus leakage or deep disunion of more than 2 cm.

Description of the patients' bacteriological testsThrough hospital admission, up to 7 days after surgery

Intraoperative samples and drain samples.

Death12 months after surgery

Obtained from the INSEE database.

Trial Locations

Locations (1)

Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP

🇫🇷

Garches, France

Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, AP-HP
🇫🇷Garches, France
François Genêt, MD-PhD
Contact
François Genêt
Principal Investigator
Hélène Le Liepvre
Sub Investigator
Vincent T. Carpentier
Sub Investigator
Aurélien Dinh
Sub Investigator
Emma D'Anglejan Chatillon
Sub Investigator
Latifa Noussair
Sub Investigator
Damien Marmouset
Sub Investigator
Haude Chaussard
Sub Investigator
Mikaël Hivelin
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.